EUVIMEDEUVIMED entdecken
Crossref

Prevalence, patient characteristics and treatment patterns among systemic lupus erythematosus–pulmonary arterial hypertension patients in real-world clinical practice: A retrospective analysis of Medical Data Vision Database in Japan

Tatsuya Atsumi, Jin Yu Tan, Ashley Pei-Chun Chiang, Dae Young Yu, Yogeshwar Makanji, David Bin-Chia Wu, Jeremy Casorso, Mahsa Kouhkamari, Sooyeol Lim

Modern Rheumatology · 06.07.2024 · 34 (4) · 741-749

DOI: 10.1093/mr/road090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Rheumatology, online erschienen am 25.09.2023. Verfasst von Tatsuya Atsumi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido, Japan. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Real-world evidence regarding prevalence, patient characteristics, and treatment patterns for pulmonary arterial hypertension (PAH) related to systemic lupus erythematosus (SLE) in Japan is limited.

Methods

We conducted a retrospective study analysing Japan’s Medical Data Vision database from April 2008 to September 2020. Prevalence, incidence, patient characteristics, treatment patterns, and use of vasodilators by treatment line were evaluated.

Results

The prevalence of PAH was 0.392% in SLE patients (n = 114/29,077). Cumulative incidence was 0.53% (3 years) and 0.77% (5 years). Of 114 SLE–PAH patients, 49% developed PAH <1 year from SLE diagnosis. SLE–PAH patients were predominantly females (88% vs. 72%), had a lower mean age at SLE diagnosis (53 vs. 56 years), and had more severe SLE (61% vs. 25%) than non-PAH–SLE patients. Glucocorticoids (58%) and vasodilators (27%) were preferred first-line monotherapy for SLE–PAH. A combination of glucocorticoids and immunosuppressants (19%) was the predominant first-line combination therapy. Endothelin receptor antagonists (40% and 44%) and nitric oxide analogues (31% and 40%) were dominant first- and second-line vasodilators.

Conclusions

SLE–PAH patients were predominantly females, were younger at diagnosis, and had more severe SLE than non-PAH–SLE patients. Most were diagnosed <1 year of SLE diagnosis. In Japan’s real-world practice, the initial treatment goal is SLE management, while vasodilators are preferred in advanced diseases, as per the Medical Data Vision database.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicHumansFemaleMaleRetrospective StudiesJapanMiddle AgedPrevalenceAdultPulmonary Arterial HypertensionVasodilator AgentsAgedDatabases, FactualGlucocorticoidsImmunosuppressive AgentsHypertension, Pulmonary

Stichwörter der Autor:innen

Prevalencepulmonary arterial hypertensionsystemic lupus erythematosustreatment patterns

Substanzen

Vasodilator AgentsGlucocorticoidsImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido, Japan.
  • Janssen Pharmaceutical Asia Pacific, Singapore.
  • Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
  • Prospection Pty Ltd, Sydney, NSW, Australia.
  • Prospection KK, Tokyo, Japan.

Zitieren

APA

Atsumi, T., Tan, J. Y., Chiang, A. P., Yu, D. Y., Makanji, Y., Wu, D. B., Casorso, J., Kouhkamari, M., & Lim, S. (2024). Prevalence, patient characteristics and treatment patterns among systemic lupus erythematosus–pulmonary arterial hypertension patients in real-world clinical practice: A retrospective analysis of Medical Data Vision Database in Japan. Modern Rheumatology, 34(4), 741-749. https://doi.org/10.1093/mr/road090

Vancouver

Atsumi T, Tan JY, Chiang AP, Yu DY, Makanji Y, Wu DB, et al. Prevalence, patient characteristics and treatment patterns among systemic lupus erythematosus–pulmonary arterial hypertension patients in real-world clinical practice: A retrospective analysis of Medical Data Vision Database in Japan. Modern Rheumatology. 2024;34(4):741-749. doi:10.1093/mr/road090

BibTeX
@article{Atsumi2024,
  author = {Atsumi, Tatsuya and Tan, Jin Yu and Chiang, Ashley Pei-Chun and Yu, Dae Young and Makanji, Yogeshwar and Wu, David Bin-Chia and Casorso, Jeremy and Kouhkamari, Mahsa and Lim, Sooyeol},
  title = {Prevalence, patient characteristics and treatment patterns among systemic lupus erythematosus–pulmonary arterial hypertension patients in real-world clinical practice: A retrospective analysis of Medical Data Vision Database in Japan},
  journal = {Modern Rheumatology},
  year = {2024},
  volume = {34},
  number = {4},
  pages = {741--749},
  doi = {10.1093/mr/road090}
}
Kostenlos starten →